Tag
This trial reveals that IVF significantly improves live birth rates compared to surgery in women with ultrasound-diagnosed deep or ovarian endometriosis-related infertility.
This phase III study demonstrates that elagolix is non-inferior to dienogest in reducing moderate-to-severe endometriosis pain, with comparable safety and tolerability profiles, supporting elagolix as a valuable treatment option.
Peritoneal fluid-derived small extracellular vesicles exhibit distinct proteomic profiles in endometriosis, identifying potential biomarkers for improved diagnosis independent of cycle phase or disease stage.
A comprehensive Danish nationwide study reveals that women with endometriosis face a significantly increased long-term risk of venous thromboembolism, underscoring the need for heightened clinical vigilance and tailored risk management.
This qualitative study explores how couples jointly cope with endometriosis, revealing shared challenges and adaptive strategies that bolster relational resilience and psychological wellbeing.
The ARCHES retrospective cohort study reveals that endometriosis significantly elevates the risk of type 2 diabetes, particularly in specific subtypes and among premenopausal women with lower BMI, highlighting the importance of subtype-spec
A nationwide French study found that hospitals performing at least 40 posterior deep infiltrating endometriosis surgeries per year had fewer severe postoperative complications, supporting referral to experienced, high-volume centers.
A U.S. national study found endometriosis surgery is shifting from inpatient to outpatient care, with hospital cases more common in older, medically complex patients and those with more extensive disease.
This review synthesizes new evidence on endometriosis symptom flares, highlighting a significant gap between patient burden and professional guidance, while integrating the latest meta-analytic findings on pharmacologic pain interventions.
Oral progestagens likely reduce overall pain and dysmenorrhoea in endometriosis, but comparative benefits over other hormonal treatments remain uncertain.
Oral progestagens reduce overall pain and dysmenorrhoea in endometriosis, but comparative benefits over other hormonal therapies remain uncertain.
A multicenter phase II trial of HMI-115, a human monoclonal antibody against the prolactin receptor, showed dose-dependent reductions in endometriosis-associated pain and preserved ovarian function, supporting larger Phase III evaluation.
A prospective multicenter study validates the high accuracy of a saliva microRNA signature for noninvasive endometriosis diagnosis, demonstrating superior performance to imaging modalities and promising clinical utility.
Women with endometriosis exhibit blunted blood pressure responses to physiological stress, challenging prior assumptions about their cardiovascular risk profile. Aspirin, a COX inhibitor, does not modify these attenuated responses.
A 30-year study reveals women with endometriosis-related infertility have higher pregnancy rates compared to other infertility causes, emphasizing the importance of early diagnosis and tailored treatments.
Research shows that a low FODMAP diet can significantly alleviate gastrointestinal symptoms in women with endometriosis, enhancing their quality of life.
Kephera Diagnostics introduces EndomTest, the first non-invasive blood test for diagnosing endometriosis, aiming to reduce diagnostic delays and improve patient care.
